Sonnet Biotherapeutics Holdings Inc. buy Chardan Capital
Start price
07.04.25
/
50%
€0.18
Target price
07.04.26
€18.22
Performance (%)
-
End price
08.04.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sonnet Biotherapeutics Holdings Inc. | - | - | - |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% |
Comments by Chardan_Capital for this prediction
In the thread Sonnet Biotherapeutics Hldgs. Inc. diskutieren
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Ratings data for SONN provided by MarketBeat
In the thread Trading Sonnet Biotherapeutics Hldgs. Inc.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
28.03.25
28.03.25
€18.53
28.03.26
28.03.26
-
30.03.26
30.03.26
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
20.12.24
20.12.24
€19.21
20.12.25
20.12.25
-
21.12.25
21.12.25
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
23.08.24
23.08.24
€26.85
23.08.25
23.08.25
-
24.08.25
24.08.25
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
28.05.24
28.05.24
€27.57
28.05.25
28.05.25
-
29.05.25
29.05.25
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
15.02.24
15.02.24
€27.86
15.02.25
15.02.25
-
16.02.25
16.02.25
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.38
16.08.23
16.08.23
€11.00
16.08.24
16.08.24
-51.06%
17.08.24
17.08.24

